People

Elbert Huang, MD

Dr. Elbert Huang is Professor of Medicine, Director of the Center for Chronic Disease Research and Policy, and Associate Director of the Chicago Center for Diabetes Translation Research at the University of Chicago. From 2010-2011, he served as a Senior Advisor in the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services.



Dr. Huang is a general internist who studies clinical and health care policy issues at the intersection of diabetes, aging, and health economics. His main research focus is in the area of medical decision making for elderly patients with type 2 diabetes where uncertainty exists regarding how to best individualize diabetes treatments based on clinical parameters and patient preferences. Over the past decade, Dr. Huang has established one of the most active research programs in geriatric diabetes in the country.



Apart from his work in geriatric diabetes, Dr. Huang has also performed other seminal translational diabetes research in the area of cost-effectiveness analysis. He performed the economic analyses of the Health Resources and Services Administration’s Health Disparities Collaboratives initiative of diabetes quality improvement in community health centers that serve the indigent. With this one study, he performed one of the first business case analyses from the perspective of the community health center as well as one of the first societal cost-effectiveness analyses of a quality improvement initiative.



Dr. Huang’s research has been supported by the National Institutes of Health, the Centers for Disease Control and Prevention, the American Diabetes Association, and the Juvenile Diabetes Research Foundation. He has received numerous honors including the Research Paper of the Year Award from the Society of General Internal Medicine and elected membership to the American Society for Clinical Investigation.



Dr. Huang received his A.B., M.D., and M.P.H. from Harvard University and came to the University of Chicago in 2001.

Harvard School of Public Health
Boston, MA
MPH - Clinical Effectiveness
2001

Massachusetts General Hospital
Boston, MA
- Fellow, General Internal Medicine Faculty Development and Fellowship Program
2001

Stanford University Medical Center
Stanford, CA
- Internship and Residency
1999

Harvard Medical School
Boston, MA
MD - Medicine
1996

Harvard College
Cambridge, MA
BA - Biology
1992

Factors associated with federally qualified health center financial performance.
Jung D, Huang ES, Mayeda E, Tobey R, Turer E, Maxwell J, Coleman A, Saber J, Petrie S, Bolton J, Duplantier D, Hoang H, Sripipatana A, Nocon R. Factors associated with federally qualified health center financial performance. Health Serv Res. 2022 Mar 09.
PMID: 35266139

Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition.
Munshi MN, Sy SL, Florez HJ, Huang ES, Lipska KJ, Myrka A, Marcos Valencia W, Yu J, Triller DM. Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition. Diabetes Ther. 2022 Mar; 13(3):535-549.
PMID: 35224691

11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022.
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S175-S184.
PMID: 34964873

13. Older Adults: Standards of Medical Care in Diabetes-2022.
13. Older Adults: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S195-S207.
PMID: 34964847

12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022.
12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S185-S194.
PMID: 34964887

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022.
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S46-S59.
PMID: 34964869

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022.
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S144-S174.
PMID: 34964815

3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022.
3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S39-S45.
PMID: 34964876

14. Children and Adolescents: Standards of Medical Care in Diabetes-2022.
14. Children and Adolescents: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S208-S231.
PMID: 34964865

1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2022.
1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S8-S16.
PMID: 34964872

View All Publications

Award for Leadership
Midwest Region Society of General Internal Medicine
2018

American Society for Clinical Investigation, Elected Member
2011

Mary Tyler Moore and S. Robert Levine, M.D., Excellence in Clinical Research Award
JDRF
2011

Leif B. Sorensen Faculty Research Award
Department of Medicine, University of Chicago
2011

Research Paper of the Year Award
Society of General Internal Medicine
2009

Presidential Poster Session Award (Preventive Medicine)
American Geriatrics Society
2007

Presidential Poster Session Award (Quality of Life)
American Geriatrics Society
2006

Merck New Investigator Award
American Geriatrics Society
2006

Junior Faculty Research Abstract Award
Midwest Society of General Internal Medicine
2001